BSO LLC
BSO LLC appears in FDA public data with 5 recalls, 0 510(k) clearances, 6 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0413-2025, Class II) was initiated on April 28, 2025.
Summary
- Total Recalls
- 5
- 510(k) Clearances
- 0
- Inspections
- 6
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0413-2025 | Class II | TESTOSTERONE PELLET 200 mg (with Cholesterol </=2%), 1 Pellet for Subcutaneous Use, This is a Compou | April 28, 2025 |
| D-0412-2025 | Class II | TESTOSTERONE PELLET 100 mg (with Cholesterol </=4%), 1 Pellet for Subcutaneous Use, This is a Compou | April 28, 2025 |
| D-0414-2025 | Class II | TESTOSTERONE PELLET 200 mg BLUNT (with Cholesterol </=2%), 1 Pellet for Subcutaneous Use, This is a | April 28, 2025 |
| D-0416-2025 | Class II | TESTOSTERONE PELLET 200 mg BLUNT, 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for | April 28, 2025 |
| D-0415-2025 | Class II | TESTOSTERONE PELLET 200 mg (with Cholesterol </=4%), 1 Pellet for Subcutaneous Use, This is a Compou | April 28, 2025 |